-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, O4vrSwN7LSpmr1+qIi2r9Aits1L7BKGhZntt2jv+q4psi3EZx/AaGtDcJ61JsYYV eijkiF6/4WYoyjIQy/VV1g== 0001004402-99-000121.txt : 19990212 0001004402-99-000121.hdr.sgml : 19990212 ACCESSION NUMBER: 0001004402-99-000121 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990211 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALPHARMA INC CENTRAL INDEX KEY: 0000730469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222095212 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-35893 FILM NUMBER: 99531316 BUSINESS ADDRESS: STREET 1: ONE EXECUTIVE DR STREET 2: P O BOX 1399 CITY: FORT LEE STATE: NJ ZIP: 07024 BUSINESS PHONE: 2019477774 FORMER COMPANY: FORMER CONFORMED NAME: A L PHARMA DATE OF NAME CHANGE: 19960513 FORMER COMPANY: FORMER CONFORMED NAME: A L LABORATORIES INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SCHRODER CAPITAL MANAGEMENT INC/NY CENTRAL INDEX KEY: 0000734634 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 132697273 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 787 SEVENTH AVENUE EQUITABLE CENTER CITY: NEW YORK STATE: NY ZIP: 10019-6016 BUSINESS PHONE: 2126413900 FORMER COMPANY: FORMER CONFORMED NAME: SCHRODER WERTHEIM INVESTMENT SERVICES INC /ADV DATE OF NAME CHANGE: 19960111 FORMER COMPANY: FORMER CONFORMED NAME: SCHRODER WERTHEIM INVESTMENT SERVICES INC /ADV DATE OF NAME CHANGE: 19960111 SC 13G 1 13(G)(2) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. SCHEDULE 13G (under the Securities Exchange Act of 1934) (Amendment No. 1) Alpharma Inc. - Class A ------------------------------- (Name of Issuer) Common Stock $0.20 Par Value ------------------------------- (Title of Class of Securities) 020813101 ----------- (Cusip Number) Check the following box if a fee is being paid with this statement [ ] . (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of more than five percent or less of such class.) (See Rule 13d-7.) * The remainder of this cover page shall be filled out for a reporting person's initial filing of this form with respect to the subject class of securities and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.) [Continued on the following page(s)] Page 1 of 4 pages - --------------------------------------------- --------------------------- CUSIP NO. 020813101 Page 2 of 4 Pages - --------------------------------------------- --------------------------- - -------- ----------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON SCHRODER CAPITAL MANAGEMENT INC. 13-2697273 - -------- ----------------------------------------------------------------------- - -------- ----------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------- ----------------------------------------------------------------------- - -------- ----------------------------------------------------------------------- 3 SEC USE ONLY - -------- ----------------------------------------------------------------------- - -------- ----------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - -------- ----------------------------------------------------------------------- - ----------------------------- -------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES 502,900 -------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY ---- -------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 571,300 -------------------------------------------------- PERSON 8 SHARED DISPOSITIVE POWER WITH ----- - ----------------------------- -------------------------------------------------- - -------- ----------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 571,300 - -------- ----------------------------------------------------------------------- - -------- ----------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------- ----------------------------------------------------------------------- - -------- ----------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 3.57% - -------- ----------------------------------------------------------------------- - -------- ----------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IA - -------- ----------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Cusip # 020813101 Page 3 of 4 Pages --------- SCHEDULE 13G Item 1 (a): Name of Issuer: - ------------------------------------------- Alpharma Inc. - Class A Item 2 (b): Address of Issuer's Principal Executive Offices: - --------------------------------------------------------------------------- Alpharma Inc. - Class A One Executive Drive Fort Lee, NJ 07024 Item 2 (a): Name of Person Filing: - -------------------------------------------------- See Item 1 of the Cover Page attached hereto Item 2 (b): Address of Principal Business Office: - ---------------------------------------------------------------- 787 Seventh Avenue -34th Floor New York, NY 10019 Item 2 (c): Citizenship: - ---------------------------------------- See Item 4 of Cover Page attached hereto Item 2 (d): Title of Class of Securities: - -------------------------------------------------------- See Cover Page attached hereto Item 2 (e): CUSIP Number: - ------------------------------------------- See Cover Page attached hereto Item 3: Type of Reporting Person: - ------------------------------------- See Item 12 of Cover Page attached hereto Item 4: Ownership: - ------------------------ (a) See Item 9 of the Cover Page attached hereto (b) Percent of Class: See Item 11 of the Cover Page attached hereto (c) For information on voting and dispositive power with respect to the above listed shares, see Items 5 - 8 of the Cover Page attached hereto. Cusip # 020813101 Page 4 of 4 Pages --------- SCHEDULE 13G Item 5. Ownership of Five Percent or Less of a Class: - --------------------------------------------------------- Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person: - ---------------------------------------------------------------------------- Not Applicable Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company: - ------------------------------------------------------------------------------- Not Applicable Item 8. Identification and Classification of Members of the Group: - ---------------------------------------------------------------------- Not Applicable Item 9. Notice of Dissolution of Group: - -------------------------------------------- Not Applicable Item 10. Certification: - --------------------------- By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. Signature: - ----------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. Date: February 8, 1999 By: Schroder Capital Management Inc. Signature: /s/ Barbara Brooke Manning ------------------------------------------------ Name/Title: Barbara Brooke Manning / First Vice President -----END PRIVACY-ENHANCED MESSAGE-----